Skip to content

Savara SVRA PP&E (Net)

PP&E (Net) at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
$5.03M-4.3%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$2.14M+343%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$5.54M-21.2%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$67.12M+15.4%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$372K+1,591%
TRV
Trevi Therapeutics, Inc.TRVI
$265K-4.3%

Other financials

Income statement

See full
Revenue-
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total equity$176.0M+19.1%
Total assets$221.6M+17.1%

Cash flow

See full
Operating cash flow-$33.0M-21.5%
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.19B+134%
Enterprise value$1.19B+127%
P/S4,648.7×

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Savara's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Savara's PP&E (net)?
Savara (SVRA) reported PP&E (net) of $130K in Q1 2026.
How has Savara's PP&E (net) changed year-over-year?
Savara's PP&E (net) decreased by 5.8% year-over-year, from $138K to $130K.
What is the long-term trend for Savara's PP&E (net)?
Over 5 years (2020 to 2025), Savara's PP&E (net) has grown at a -8.5% compound annual growth rate (CAGR), from $156K to $100K.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.